EP Patent

EP4616859A1 — Room temperature stability of ophthalmological compositions comprising aceclidine

Assigned to Lenz Therapeutics Operations Inc · Expires 2025-09-17 · 1y expired

What this patent protects

The present disclosure provides aqueous compositions comprising aceclidine that are stable at room temperature for prolonged periods of time.

USPTO Abstract

The present disclosure provides aqueous compositions comprising aceclidine that are stable at room temperature for prolonged periods of time.

Drugs covered by this patent

Patent Metadata

Patent number: EP4616859A1
Jurisdiction: EP
Classification: —
Expires: 2025-09-17
Drug substance claim: No
Drug product claim: No
Assignee: Lenz Therapeutics Operations Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.